On the time of its acquisition by the Shiseido Group in 2022, Gallinée generated 95% of its gross sales via on-line channels. Since then, the model has considerably expanded its footprint throughout Europe and now counts 1,250 lively factors of sale. This profitable integration relies on combining Gallinée’s consumer-centric, microbiome-driven strategy with Shiseido’s analysis capabilities.
Pilot model
Right this moment, Gallinée performs a key function within the improvement of Shiseido’s pharmacy channel throughout Europe. The French microbiome specialist acts as a pilot model throughout the European dermocosmetics market, enabling the group to construct and deploy a technique tailor-made to the pharmacy market, recognized as a precedence progress driver.
“Gallinée completely illustrates our ambition to develop science-driven skincare manufacturers throughout the pharmacy channel, the place experience, belief {and professional} suggestion are important,” explains Florian d’Hauteville, Chief Enterprise Officer, Shiseido EMEA. “Its progressive enlargement on this distribution channel is a part of a long-term progress technique constructed on science, operational excellence and sustainable worth creation.”
The model now plans to speed up its improvement with the opening of a minimum of 300 pharmacies per nationwide market, with a longer-term ambition of increasing to five,000 pharmacies throughout France, Italy, and Spain.
Microbiome-focused innovation
The transfer into the pharmacy channel — an surroundings grounded in belief and skilled suggestion — was a pure match for a model devoted to addressing pores and skin well being issues.
On the coronary heart of Gallinée’s technique lies a easy philosophy: help the pores and skin’s ecosystem with out disrupting it.
“This strategy is absolutely aligned with Shiseido’s scientific technique, which has established the microbiome as a key pillar of its analysis and innovation,” says Marie Drago, Founder and Chief Inventive Officer of Gallinée. The Group attracts on devoted analysis facilities, bringing collectively experience in formulation, toxicology, security evaluation and high quality management, to develop a deeper understanding of the interactions between the pores and skin and its microbiome.
Right this moment, Gallinée advantages from structured microbiome experience and an innovation pipeline protected by mental property. The model holds 4 patents underpinning a particular “microbiome system.” Amongst these patents is the usage of vinegar as a postbiotic ingredient, a primary in skincare.
“Becoming a member of the Shiseido Group has enabled us to speed up our progress with out ever compromising our DNA. Increasing into pharmacy was a pure step: it’s a channel the place we are able to converse critically about pores and skin steadiness and long-term care. Growing our presence whereas remaining clear and really helpful to customers is strictly what we’re constructing at this time,” provides Marie Drago.
First-to-market merchandise
This structured enlargement is supported by the sturdy efficiency of Gallinée’s iconic merchandise, beginning with the Face Vinegar, now bought each half-hour worldwide, almost ten years after its launch. In 2025, gross sales of the Vinegar vary doubled in comparison with 2024, confirming its standing as a flagship franchise for the model. The Vinegar vary accounts for 23% of whole model gross sales in 2025, whereas the Common vary stays the model’s main pillar, representing 28% of whole gross sales.
On the similar time, Gallinée continues to drive sustained innovation. The Youthful Eye Cream entered the model’s prime 5 references after simply 4 months available on the market in 2025. Since becoming a member of Shiseido, Gallinée has launched 5 new facial merchandise, all made in France.
